欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4476/001
药品名称Mebeverine Aristo 200 mg modified release capsules, hard
活性成分
    • Mebeverine hydrochloride 200.0 mg
剂型Modified-release capsule, hard
上市许可持有人Aristo Pharma GmbH Wallenroder Str. 8-10 13435 Berlin Germany
参考成员国 - 产品名称Netherlands (NL)
Mebeverine HCl Aristo 200 mg harde capsules met gereguleerde afgifte
互认成员国 - 产品名称
    • Germany (DE)
      Mebeverine Aristo 200 mg Retardkapseln
    • Denmark (DK)
      Mebeverinhydrochlorid "Aristo"
    • Austria (AT)
      Mebeverin Aristo 200 mg Hartkapseln mit veränderter Wirkstofffreisetzung
    • Portugal (PT)
    • Poland (PL)
      Mebeverine Aristo
许可日期2019/09/26
最近更新日期2024/10/03
药物ATC编码
    • A03AA04 mebeverine
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase